Eleutheroside E | CAS:39432-56-9 | Manufacturer ChemFaces

Eleutheroside E

Citing Use of our Products

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Sent to Email: info@chemfaces.com

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Fax: (0086)-27-84254680
E-mail: manager@chemfaces.com
Address: No. 83, CheCheng Rd., WETDZ, Wuhan, Hubei 430056, PRC

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal & Western Union

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $49.2 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

Bruceine D

Catalog No: CFN90771
CAS No: 21499-66-1
Price: $258/10mg

Robinin

Catalog No: CFN98375
CAS No: 301-19-9
Price: $498/10mg

4-O-Feruloylquinic acid

Catalog No: CFN92392
CAS No: 2613-86-7
Price: $448/5mg

Scopolin

Catalog No: CFN98887
CAS No: 531-44-2
Price: $168/20mg

Pd-C-II

Catalog No: CFN95003
CAS No: N/A
Price: $358/5mg

Isonemerosin

Catalog No: CFN95008
CAS No: 181524-79-8
Price: $268/20mg

Sibiricaxanthone B

Catalog No: CFN90644
CAS No: 241125-81-5
Price: $238/20mg

Description:

Eleutheroside E(EE) has anti-inflammatory and protective effects in ischemia heart, the beneficial effect of EE may provide an effective and powerful strategy to alleviate behavioral alterations induced by sleep deprivation, it may influence to immune-enhancing through increasing the physical endurance capacity and immune cell activation. EE significantly decreases the inflammatory cell infiltration, pannus formation, cartilage damage, bone erosion of CIA mice, the generation of TNF-α and IL-6, the metabolism of drugs metabolized via CYP2C9 and CYP2E1.

Targets:

NF-kB | TNF-α | IL Receptor | P450 (e.g. CYP17) | IFN-γ

In vitro:

Oriental Pharmacy & Experimental Medicine, 2010, 10(3):191-9.

Immune-enhancing effect of Acanthopanax Koreanum and its component, Eleutheroside E on the protein-energy malnourished C57bl/6 mice[Reference: WebLink]

Acanthopanax Koreanum stem (AK) has been used in Korea as a tonic and sedative as well as a drug with ginseng like activities.
METHODS AND RESULTS:
The purpose of our present study was to investigate the effects of AK extract (AKE) and Eleutheroside E, major component of AKE on an exacerbated immune function through utilization of protein-energy malnutrition (PEM) diet by using forced swimming test (FST). The immobility time were significantly decreased in the AKE or Eleutheroside E-administrated group compared with the control group on the FST (P compared with unstimulated splenocytes but not interleukin (IL)-4. Eleutheroside E also significantly increased the IFN-\gamma production but not IL-2 and IL-4 in T cell line, MOLT-4 cells.
CONCLUSIONS:
These results suggest that AKE and Eleutheroside E may influence to immune-enhancing through increasing the physical endurance capacity and immune cell activation.

In vivo:

Eur J Pharmacol. 2011 May 11;658(2-3):150-5.

The effect of Eleutheroside E on behavioral alterations in murine sleep deprivation stress model.[Pubmed: 21376030 ]

Eleutheroside E (EE), a principal component of Eleutherococcus senticosus, has been reported to have anti-inflammatory and protective effects in ischemia heart etc. However, whether it can mitigate behavioral alterations induced by sleep deprivation, has not yet been elucidated. Numerous studies have demonstrated that memory deficits induced by sleep deprivation in experimental animals can be used as a model of behavioral alterations. The present study investigated the effect of EE, on cognitive performances and biochemical parameters of sleep-deprived mice.
METHODS AND RESULTS:
Animals were repeatedly treated with saline, 10 or 50mg/kg EE and sleep-deprived for 72 h by the multiple platform method. Briefly, groups of 5-6 mice were placed in water tanks (45 × 34 × 17 cm), containing 12 platforms (3 cm in diameter) each, surrounded by water up to 1cm beneath the surface or kept in their home cage. After sleep deprivation, mice showed significant behavioral impairment as evident by reduced latency entering into a dark chamber, locomotion and correctly rate in Y maze, and increased monoamines in hippocampus. However, repeated treatment with EE restored these behavioral and biochemical alterations in mice.
CONCLUSIONS:
In conclusion, the beneficial effect of EE may provide an effective and powerful strategy to alleviate behavioral alterations induced by sleep deprivation.

Eleutheroside E Description

Source:	The roots of Eleutherococcus senticosus
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Cell Research:

BMC Complement Altern Med. 2014 Jan 2;14:1.

Effects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes.[Pubmed: 24383621]

Chemicals of herbal products may cause unexpected toxicity or adverse effect by the potential for alteration of the activity of CYP450 when co-administered with other drugs. Eleutherococcus senticosus (ES), has been widely used as a traditional herbal medicine and popular herbal dietary supplements, and often co-administered with many other drugs. The main bioactive constituents of ES were considered to be eleutherosides including eleutheroside B (EB) and Eleutheroside E (EE). This study was to investigate the effects of EB and EE on CYP2C9, CYP2D6, CYP2E1 and CYP3A4 in rat liver microsomes in vitro.
METHODS AND RESULTS:
Probe drugs of tolbutamide (TB), dextromethorphan (DM), chlorzoxazone (CLZ) and testosterone (TS) as well as eleutherosides of different concentrations were added to incubation systems of rat liver microsomes in vitro. After incubation, validated HPLC methods were used to quantify relevant metabolites. The results suggested that EB and EE exhibited weak inhibition against the activity of CYP2C9 and CYP2E1, but no effects on CYP2D6 and CYP3A4 activity. The IC50 values for EB and EE were calculated to be 193.20 μM and 188.36 μM for CYP2E1, 595.66 μM and 261.82 μM for CYP2C9, respectively. Kinetic analysis showed that inhibitions of CYP2E1 by EB and EE were best fit to mixed-type with Ki value of 183.95 μM and 171.63 μM, respectively.
CONCLUSIONS:
These results indicate that EB and EE may inhibit the metabolism of drugs metabolized via CYP2C9 and CYP2E1, and have the potential to increase the toxicity of the drugs.

Animal Research:

Inflammation. 2014 Oct;37(5):1533-43.

Eleutheroside E ameliorates arthritis severity in collagen-induced arthritis mice model by suppressing inflammatory cytokine release.[Pubmed: 24917466]

Rheumatoid arthritis is the most common arthritis and is mainly characterized by symmetric polyarticular joint disorders. Eleutheroside E (EE), a principal active constituent of Acanthopanax senticosus, is reported to have anti-inflammatory effect by inhibiting NF-κB activities. However, the effects of EE on rheumatoid arthritis (RA) severity are largely unknown.
METHODS AND RESULTS:
The purpose of this study was to indicate whether EE could ameliorate arthritis and reduce inflammatory cytokine release in collagen-induced arthritis (CIA) mice. The results showed that EE attenuated the severity of arthritis by reducing the mean arthritis score and arthritis incidence. EE also significantly decreased the inflammatory cell infiltration, pannus formation, cartilage damage, and bone erosion of CIA mice. Furthermore, EE caused a marked decrease of the production of TNF-α and IL-6 in vivo and in vitro.
CONCLUSIONS:
These observations identify a novel function of EE that results in inhibition of cytokine release, highlighting EE was a potential therapeutic agent for RA.

Structure Identification:

Arch Pharm Res. 2015 Nov;38(11):1921-5.

Utilization of circular dichroism experiment to distinguish acanthoside D and eleutheroside E.[Pubmed: 25802110 ]

Two lignan glycosides, acanthoside D (1) (=liriodendrin, (+)-syringaresinol di-O-β-D-glucopyranoside) and Eleutheroside E (2) have been confused each other for so long time, and hard to be distinguished each other. Now, this two compounds need to be defined properly so that all the commercial mistakes and confusions should not be made.
METHODS AND RESULTS:
They have identical planar structures except for the configurations at C-7 and C-8 in each structure according to the chemistry database, SciFinder(®). The systematic name of acanthoside D is [(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis(2,6-dimethoxy-4,1-phenylene) bis-β-D-glucopyranoside (1), and the name of Eleutheroside E is [(1R,3aR,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis(2,6-dimethoxy-4,1-phenylene) bis-β-D-glucopyranoside (2). The differences at two chiral centers do not make any differences in the NMR spectra. Thus, the circular dichroism were utilized to dissolve this difficult problem.
CONCLUSIONS:
Acanthoside D (1) showed a positive Cotton effect at 200 nm, whereas Eleutheroside E (2) exhibited a negative cotton effect at 200 nm. The absolute structure of acanthoside D was also confirmed by X-ray crystallography.

CAS No.	39432-56-9	Price	$88 / 20mg
Catalog No.	CFN99984	Purity	>=98%
Molecular Weight	742.73	Type of Compound	Lignans
Formula	C₃₄H₄₆O₁₈	Physical Description	Powder
Download	Manual COA MSDS SDF	Similar structural	Comparison (Web) (SDF)

Product Name	Eleutheroside E
CAS No.:	39432-56-9
Catalog No.:	CFN99984
Molecular Formula:	C₃₄H₄₆O₁₈
Molecular Weight:	742.73 g/mol
Purity:	>=98%
Type of Compound:	Lignans
Physical Desc.:	Powder
Targets:	NF-kB \| TNF-伪 \| IL Receptor \| P450 (e.g. CYP17) \| IFN-纬
Source:	The roots of Eleutherococcus senticosus
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Price:	$88 / 20mg

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Anti-inflammatory Compound Library Cardioprotective Compound Library Immunomodulators Compound Library Anti-osteoarthritis Compound Library Lignans Compound Library TNF-α Inhibitor Library P450 (e.g. CYP17) Inhibitor Library NF-kB Inhibitor Library IL Receptor Inhibitor Library IFN-γ Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	1.3464 mL	6.7319 mL	13.4638 mL	26.9277 mL	33.6596 mL
5 mM	0.2693 mL	1.3464 mL	2.6928 mL	5.3855 mL	6.7319 mL
10 mM	0.1346 mL	0.6732 mL	1.3464 mL	2.6928 mL	3.366 mL
50 mM	0.0269 mL	0.1346 mL	0.2693 mL	0.5386 mL	0.6732 mL
100 mM	0.0135 mL	0.0673 mL	0.1346 mL	0.2693 mL	0.3366 mL

CFN98174	Fargesin	31008-19-2	370.39	C₂₁H₂₂O₆
CFN90628	Asarinin	133-05-1	354.35	C₂₀H₁₈O₆
CFN98510	Eleutheroside D	79484-75-6	742.72	C₃₄H₄₆O₁₈
CFN99984	Eleutheroside E	39432-56-9	742.73	C₃₄H₄₆O₁₈
CFN92287	(-)-Pinoresinol	81446-29-9	358.4	C₂₀H₂₂O₆
CFN92500	(-)-Syringaresinol	6216-81-5	418.4	C₂₂H₂₆O₈
CFN97537	Hedyotisol A	95732-59-5	810.9	C₄₂H₅₀O₁₆
CFN97877	Hedyotisol B	95839-45-5	810.9	C₄₂H₅₀O₁₆
CFN99504	(-)-Syringaresinol 4-(2''-apiosylglucoside)	136997-64-3	712.69	C₃₃H₄₄O₁₇
CFN92288	(+)-Epipinoresinol	24404-50-0	358.4	C₂₀H₂₂O₆